10-17961683-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001145195.2(SLC39A12):c.364A>G(p.Ile122Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145195.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A12 | NM_001145195.2 | c.364A>G | p.Ile122Val | missense_variant | 3/13 | ENST00000377369.7 | NP_001138667.1 | |
SLC39A12 | NM_001282733.2 | c.364A>G | p.Ile122Val | missense_variant | 3/13 | NP_001269662.1 | ||
SLC39A12 | NM_152725.4 | c.364A>G | p.Ile122Val | missense_variant | 3/12 | NP_689938.2 | ||
SLC39A12 | NM_001282734.2 | c.-39A>G | 5_prime_UTR_variant | 2/12 | NP_001269663.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A12 | ENST00000377369.7 | c.364A>G | p.Ile122Val | missense_variant | 3/13 | 1 | NM_001145195.2 | ENSP00000366586 | A1 | |
SLC39A12 | ENST00000377371.3 | c.364A>G | p.Ile122Val | missense_variant | 3/13 | 1 | ENSP00000366588 | P4 | ||
SLC39A12 | ENST00000377374.8 | c.364A>G | p.Ile122Val | missense_variant | 3/12 | 2 | ENSP00000366591 | |||
SLC39A12 | ENST00000539911.5 | c.-39A>G | 5_prime_UTR_variant | 2/12 | 2 | ENSP00000440445 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.364A>G (p.I122V) alteration is located in exon 3 (coding exon 2) of the SLC39A12 gene. This alteration results from a A to G substitution at nucleotide position 364, causing the isoleucine (I) at amino acid position 122 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.